Mucormycosis treated with posaconazole: review of 96 case reports.
about
Therapeutic Drug Monitoring of Posaconazole: an UpdateCombination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of MucoralesHow should we manage a patient with invasive mucoromycosis who develops life-threatening reaction to amphotericin B? Report of two cases and literature review.Effective treatment of cerebral mucormycosis associated with brain surgeryMedical management of invasive fungal infections of the central nervous system in pediatric cancer patients.Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazoleAn unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae.Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.Bone and joint infections by Mucorales, Scedosporium, Fusarium and even rarer fungi.Our 2014 approach to mucormycosis.Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review.The role of surgical debridement in different clinical manifestations of invasive aspergillosis.Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections.Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK.New facets of antifungal therapy.Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis.Pathogenicity of Conidiobolus coronatus and Fusarium solani in mouse models.A Nontraumatic Surprise Neck Mass.Posaconazole in lung transplant recipients: use, tolerability, and efficacy.Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.Mind the gap: Management of an emergent and threatening invasive fungal infection-a case report of rhino-orbital-cerebral and pulmonary mucormycosis.Marked peripheral eosinophilia due to prolonged administration of posaconazole.Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.Primary cutaneous Rhizopus folliculitis in an immunocompetent woman.Mucormycosis in Children: Review and Recommendations for Management.Refractory bronchovascular pleuropulmonary mucormycosis: Case report and difficulties in management.Stem cell transplantation for acute myeloid leukemia with pulmonary and cerebral mucormycosis.Cutaneous mucormycosis caused by Rhizopus microsporus in an immunocompetent patient: A case report and review of literature.
P2860
Q26746016-1CC74BF2-FF8A-45DC-BD4E-BAA77B183EE5Q30873926-F2E16945-79AC-488B-8036-ADE2842A3B85Q35076896-5D4ECBAA-AA9F-47C0-9FD9-31E1D538A807Q35196776-FBCE5539-DC31-473A-AF58-17927328EAA8Q35449392-EC25A441-F4F4-4267-844A-6A1309435D0EQ35513374-BA34BEB9-DEBB-45C3-B741-28586DE2C846Q35732778-FA88A78D-9ADD-4394-B27E-1FD1473543DBQ37009706-B0BDB782-C8EF-4C70-AC18-A92481C09044Q37203849-CFF51EAC-B4E3-4411-8985-A58857E5CDA1Q38210282-009E51BC-3E87-4B05-A4BC-AE62BF8B9918Q38211830-95D04F36-F716-42DD-B106-305D46706695Q38225122-33A01411-5380-4FDB-9984-ED73BB38699FQ38245929-0CA98148-9BAE-4AC4-95D6-6F9A2EC0C0B5Q38321383-2D47DEEB-E5FA-405D-9386-B0A284A872B5Q38341595-05B21F64-EE5F-479B-AF69-DC84377DD128Q38353420-5348CC08-5907-43B1-8C4D-26FF42537E88Q38644817-F1800194-D7D8-4267-82A6-7C90A25AAA90Q38758268-BDCB0323-CF92-4A30-9DC0-AEF920789FC7Q38797864-E8283C94-00D0-4F31-9930-77DC14F5BB75Q39575509-DF8D5AEA-5DEE-4E40-A48D-D176FA53C41CQ40316553-7A962D9F-2CD1-491F-BC81-18ABE731C417Q40542667-78B9F3E7-0C7D-48DA-A3EE-E95A6192279BQ40827808-3BAB12F5-EEFA-4DFC-8222-77371DA7E4A8Q40965373-216A9DBB-7F43-4B43-931F-BEA0736B1C89Q41860941-9FF83AF3-2379-46C0-9F6D-AD179B538A21Q42273837-ECC8A3C3-D0F8-4112-A491-247B12AF73A7Q46834709-56068BBF-B1A7-4D94-B5BE-0B932D87A048Q47127509-6E1FCB96-ED48-455A-9645-EE79DAF6EE6DQ47222680-51D5E2D4-6B49-447D-9218-121D38B8C801Q47661337-5EBF886A-C6F3-43BF-AA2E-EF4B0BCC737EQ52145216-098F9261-8DDA-4CF9-A4EA-5B32FEDAF5E0Q55446377-BC30B436-A991-49E4-9C88-2A866253861D
P2860
Mucormycosis treated with posaconazole: review of 96 case reports.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mucormycosis treated with posaconazole: review of 96 case reports.
@en
type
label
Mucormycosis treated with posaconazole: review of 96 case reports.
@en
prefLabel
Mucormycosis treated with posaconazole: review of 96 case reports.
@en
P2093
P1476
Mucormycosis treated with posaconazole: review of 96 case reports
@en
P2093
Andrea Birtel
Angela Steinbach
Fedja Farowski
Gerd Fätkenheuer
Joerg J Vehreschild
Kerstin Wahlers
Maria J G T Vehreschild
Matthias Kochanek
Michal Sieniawski
P304
P356
10.3109/1040841X.2012.711741
P407
P577
2012-08-24T00:00:00Z